Prescription Information Modernization Act of 2025 allows digital communication of FDA-approved drug prescribing information.
The Prescription Information Modernization Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to allow for digital communication of FDA-approved prescribing information for drugs, including biological products. Manufacturers must still provide prescribers and dispensers with the option to receive information in paper form or request it as needed. The Secretary of Health and Human Services must issue regulations within one year to implement these changes and minimize economic impacts on prescribers and dispensers.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.